Given survivin’s roles in cancer cell proliferation, survival, metastasis, and therapeutic resistance30–32,34,35, dn-ATF5-induced survivin depletion is highly likely to contribute to dn-ATF5’s anti-tumor actions. This evidence concerns the gene BIRC5 and cancer.